相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT
Linda J. W. Bosch et al.
CANCER PREVENTION RESEARCH (2012)
Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology
Hongzhi Zou et al.
CLINICAL CHEMISTRY (2012)
Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates
Barry M. Berger et al.
PATHOLOGY (2012)
Molecular Tests for Colorectal Cancer Screening
Linda J. W. Bosch et al.
CLINICAL COLORECTAL CANCER (2011)
Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: A meta-analysis
Y. -X. Luo et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test
F. A. Oort et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Contrasting US and European approaches to colorectal cancer screening: which is best?
Geir Hoff et al.
GUT (2010)
Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
Sabine C. Gloeckner et al.
CANCER RESEARCH (2009)
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
Debby M. E. I. Hellebrekers et al.
CLINICAL CANCER RESEARCH (2009)
N-Myc Downstream-Regulated Gene 4 (NDRG4): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer
Veerle Melotte et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Sensitive digital quantification of DNA methylation in clinical samples
Meng Li et al.
NATURE BIOTECHNOLOGY (2009)
Promoter DNA Methylation of Oncostatin M receptor-β as a Novel Diagnostic and Therapeutic Marker in Colon Cancer
Myoung Sook Kim et al.
PLOS ONE (2009)
A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection
Steven Itzkowitz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Stool DNA and occult blood testing for screen detection of colorectal neoplasia
David A. Ahlquist et al.
ANNALS OF INTERNAL MEDICINE (2008)
Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients
Frank Diehl et al.
GASTROENTEROLOGY (2008)
Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening
Dao-Rong Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
A quantitative immunochemical fecal occult blood test for colorectal neoplasia
Zohar Levi et al.
ANNALS OF INTERNAL MEDICINE (2007)
Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells
ML Janmaat et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests
J Olson et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2005)
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype
JC Brandes et al.
CARCINOGENESIS (2005)
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
TF Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test
D Whitney et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel
DA Ahlquist et al.
GASTROENTEROLOGY (2000)